NASDAQ: TLXTelix Pharmaceuticals Ltd Stock Ownership - Who owns Telix Pharmaceuticals?
Insider buying vs selling
Have Telix Pharmaceuticals Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when TLX insiders and whales buy or sell their stock.
TLX Shareholders
What type of owners hold Telix Pharmaceuticals Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Christian Behrenbruch | 6.18% | 20,929,006 | $217.66M | Insider |
| Mark Alexander Nelson | 1.07% | 3,628,750 | $37.74M | Insider |
| Jann Elizabeth Skinner | 0.18% | 595,000 | $6.19M | Insider |
| David Norman Cade | 0.11% | 373,133 | $3.88M | Insider |
| Portland Investment Counsel Inc | 0.08% | 266,200 | $2.77M | Institution |
| Lazard Asset Management LLC | 0.07% | 250,517 | $2.61M | Institution |
| Fmr LLC | 0.04% | 123,570 | $1.29M | Institution |
| Jpmorgan Chase Co | 0.02% | 74,368 | $773.43k | Institution |
| Marshall Wace LLP | 0.01% | 46,658 | $485.24k | Institution |
| Private Advisor Group LLC | 0.01% | 46,345 | $481.99k | Institution |
TLX vs Biotech Stocks
Telix Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.